We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Takeda Pharmaceutical Company Ltd | NYSE:TAK | NYSE | Depository Receipt |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
13.08 | 13.005 | 13.08 |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
00:56:28 | 2 | 13.54 | USD |
Date | Time | Source | Headline |
---|---|---|---|
09/11/2023 | 20:25 | DJN | Takeda Gets FDA Approval For Blood-Clotting Disorder Treatment |
08/11/2023 | 23:49 | DJN | Takeda Says FDA Approves Treatment for Colorectal Cancer |
02/10/2023 | 22:16 | DJN | Takeda to Voluntarily Withdraw Exkivity Following Talks with FDA |
28/9/2023 | 13:40 | DJN | Correction to Takeda Headline and Article on Sept. 27 |
27/9/2023 | 22:13 | DJN | Takeda Gets FDA Approval for Ulcerative Colitis Therapy |
15/6/2023 | 16:30 | DJN | Hutchmed, Takeda's Fruquintinib Accepted for Regulatory Review by EMA |
Takeda Pharmaceutical (TAK) Charts1 Year Takeda Pharmaceutical Chart |
|
1 Month Takeda Pharmaceutical Chart |
Intraday Takeda Pharmaceutical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions